Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Construction, expression and functional characterization of an engineered antibody against tumor antigen MUC-1C. / Pourjafar, Mona; Miehe, Michaela; Najafi, Rezvan et al.
In: Protein Expression and Purification, Vol. 199, 106148, 11.2022.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
}
TY - JOUR
T1 - Construction, expression and functional characterization of an engineered antibody against tumor antigen MUC-1C
AU - Pourjafar, Mona
AU - Miehe, Michaela
AU - Najafi, Rezvan
AU - Soleimani, Meysam
AU - Spillner, Edzard
N1 - Publisher Copyright: © 2022
PY - 2022/11
Y1 - 2022/11
N2 - Minibodies (single-chain Fv-CH3) are fusion proteins of a single-chain variable fragment (scFv) to the human IgG1 CH3 domain. They exhibit superior properties as compared to whole antibodies due to their smaller size and less complex composition, and also as compared to scFvs due to the two antigen-binding domains, for immunotherapy and imaging of various carcinomas including breast cancer. In the current study, efficient production of the recombinant anti-MUC-1 minibody for its dominant format (VH-VL) was obtained in the periplasmic space of the Escherichia coli BL21 (DE3) expression system. The active recombinant protein was successfully purified from soluble fraction. Functional assays presented the in vitro targeting properties and specificity of the expressed anti-MUC-1 HL minibody in the MUC-1 positive cell lines compared to normal cell.
AB - Minibodies (single-chain Fv-CH3) are fusion proteins of a single-chain variable fragment (scFv) to the human IgG1 CH3 domain. They exhibit superior properties as compared to whole antibodies due to their smaller size and less complex composition, and also as compared to scFvs due to the two antigen-binding domains, for immunotherapy and imaging of various carcinomas including breast cancer. In the current study, efficient production of the recombinant anti-MUC-1 minibody for its dominant format (VH-VL) was obtained in the periplasmic space of the Escherichia coli BL21 (DE3) expression system. The active recombinant protein was successfully purified from soluble fraction. Functional assays presented the in vitro targeting properties and specificity of the expressed anti-MUC-1 HL minibody in the MUC-1 positive cell lines compared to normal cell.
KW - Breast cancer
KW - Engineered antibody
KW - Mammalian expression
KW - Minibody
KW - Mucin-1
KW - Periplasmic expression
U2 - 10.1016/j.pep.2022.106148
DO - 10.1016/j.pep.2022.106148
M3 - Journal article
C2 - 35940518
AN - SCOPUS:85135701459
VL - 199
JO - Protein Expression and Purification
JF - Protein Expression and Purification
SN - 1046-5928
M1 - 106148
ER -